Remedium Lifecare posts consolidated Q2 FY26 net profit higher at Rs. 8.62 Cr
Consolidated revenue from operations stood at Rs. 111.05 crore
Consolidated revenue from operations stood at Rs. 111.05 crore
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
ALBIS will present a selection of advanced materials from its broad healthcare portfolio
SMDC is a participating authority under Pharmaceutical Inspection Cooperation Scheme (PIC/S)
This collaboration turns kitting into a strategic advantage for sponsors and sites
Diroximel fumarate delayed-release capsules, 231 mg, are indicated for the treatment of relapsing forms of multiple sclerosis
Dexlansoprazole delayed-release capsules are a proton pump inhibitor
LANXESS will highlight its commitment to combatting antimicrobial resistance by presenting science-based disinfection solutions
OncoMate MSI Dx Analysis System is a PCR-based assay designed to evaluate MSI status in tumor tissue
Subscribe To Our Newsletter & Stay Updated